Autopsy report · NCT03303235

Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections

“Collaborators left the institution.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Early Phase 1

Sponsor

Johns Hopkins University

Sponsor type

University, hospital or other

Conditions

Uterine Atony; Uterine Tone Disorders; Postpartum Hemorrhage

Interventions

Methylergonovine

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Virtual Reality in Wide-Awake Hand Surgery
  “Researchers left institution” (77% match in meaning)
• Prediction of Ovarian Malignancy in the Presence of Sonographic Pelvic Mass
  “The researcher Left the organization” (75% match in meaning)
• Efficacy of Silver Nanoparticle Gel Versus a Common Antibacterial Hand Gel
  “Researcher left the institution” (73% match in meaning)
• Cardiac Hemodynamics in Overlap Syndrome (COPD With Obstructive Sleep Apnea)
  “the fellow interested in this project left the institution” (68% match in meaning)
• Different Modes of Temperature Measurement in the Emergency Department
  “The investigator left the organization” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.